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The evidence for a role of vasospasm 
in the pathogenesis of cerebral malaria
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Abstract 
Due to delay in treatment, cerebral malaria (CM) remains a significant complication of Plasmodium falciparum 
infection and is a common cause of death from malaria. In addition, more than 10 % of children surviving CM have 
neurological and long-term cognitive deficits. Understanding the pathogenesis of CM enables design of supportive 
treatment, reducing neurological morbidity and mortality. Vaso-occlusion and brain swelling appear to be leading 
to clinical features, neuronal damage and death in CM. It is proposed that parasitized red blood cells (pRBC), due to 
cytoadhesion to the endothelium and vasospasm induced by reduced bioavailability of nitric oxide, are causes. Stasis 
of blood flow and accumulation of pRBC may allow, after schizont rupture, for high concentration of products of 
haemolysis to accumulate, which leads to localized nitric oxide depletion, inducing adhesion molecules and cerebral 
vasospasm. Features consistent with an involvement of vasospasm are rapid reversibility of neurological symptoms, 
intermittently increased or absent flow in medium cerebral artery detectable on Doppler ultrasound and hemispheric 
reversible changes on cerebral magnetic resonance imaging in some patients. Clinical trials of treatment that can rap-
idly reduce cerebral vasospasm, including nitric oxide donors, inhaled nitric oxide, endothelin or calcium antagonists, 
or tissue plasminogen activators, are warranted.
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Background
A significant proportion of the 584,000 (95  % uncer-
tainty interval, 367,000–755,000) malaria deaths in 2013 
[1] were due to cerebral malaria (CM). The majority of 
affected children were living in sub-Saharan Africa and 
were under 5  years old. For clinical purposes, CM has 
been defined by the WHO as an encephalopathy, where 
asexual Plasmodium falciparum parasitaemia is detect-
able in peripheral blood and without an alternative cause. 
Even with optimal care CM was reported to have a mor-
tality of 15–25  % in children and 20  % in adults [2, 3]. 
Fifty to 75 % of deaths were found to occur within 24 h 
of admission to hospital [4]. This means any support-
ive treatment aimed at reducing mortality in CM has to 
be able to rapidly reverse key pathophysiological events 
leading to CM. Targeting inflammatory cascades or the 
sequestered parasites, which have been associated with 
the pathogenesis of CM, may take effect with a delay of 
days. Targeting the end result of brain swelling, which is 
linked to mortality [2] by osmotic therapy, has not been 
successful [5]. There is, therefore, an urgent need to iden-
tify rapidly reversible mechanisms of CM.
Mouse models have been used to investigate potential 
treatments for human CM. The cerebral pathology in 
the mouse model of CM (experimental cerebral malaria 
(ECM)) is fundamentally different from human CM in 
the sense that in Plasmodium berghei (ANKA strain) 
infection of C57BL/6 or CBA mice, the CM is character-
ized by sequestration of leukocytes in the brain, while in 
human CM mainly parasitized red blood cells (pRBC) 
are sequestered. Conclusions drawn from findings in 
this model may not apply to humans [6]. Mice depleted 
of lymphocytes do not develop white cell sequestration 
in the brain. Vasospasm has, on the basis of histopatho-
logical findings, first been proposed to be involved in 
human CM by Polder et  al. [7] and would be accessible 
to treatment successfully applied in other diseases asso-
ciated with cerebral vasospasm, such as sub-arachnoid 
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haemorrhage. This review had the objective to identify 
and summarize features of cerebral vasospasm in previ-
ous studies of human CM and explore how these find-
ings could be used to lay the foundations of therapeutic 
approaches.
Review
Key features of cerebral malaria
Neurological features of acute CM and long-term neu-
rological deficits were comprehensively reviewed previ-
ously [4]. Following the WHO definition, an essential 
feature of CM is coma with the inability to localize pain-
ful stimuli. Investigation of brain activity during coma 
revealed bilateral slowing on electroencephalography. 
Seizures may occur in up to 60  % of hospitalized chil-
dren. Seizures are less common in adults where they 
occur in 20 %. There may be brainstem signs, including 
abnormal eye movements, changes in pupillary size and 
reaction, absence of corneal and oculocephalic reflexes, 
disorders of conjugate gaze and abnormal breathing pat-
terns, abnormal posture, and abnormalities of tone and 
reflexes. Such signs are more common in children than in 
adults. Recovery of consciousness occurs usually within 
48  h. Features of poor prognosis for survival and long-
term morbidity were deep coma, multiple and prolonged 
seizures and absent corneal and oculocephalic reflexes. 
Elevated lactate levels in plasma and cerebrospinal fluid 
were linked to increased mortality.
Electroencephalography during seizures showed that 
the origin of seizures was often the temporo-parietal 
region (a watershed area). The review authors suggested 
that this may indicate that ischaemia and hypoxia are 
involved in its aetiology.
Neurological deficits in survivors of cerebral malaria
Neurological deficits in children with CM summarized 
from previous studies [4] were identifiable in 11  % and 
include hemiparesis (4.4 %), quadriparesis (3.5 %), ataxia 
(2.5  %), visual (2.3  %) and speech (2.1  %) impairments, 
hearing loss (1.9 %) and behavioural difficulties (1.3 %).
In adults neurological deficits as sequelae were 
observed in less than 5 % and characteristically included 
extrapyramidal tremor and other cerebellar signs, cranial 
nerve palsies, mononeuritis multiplex, and polyneuropa-
thy [4]. In the majority of survivors of CM neurological 
deficits were reversible.
The result of imaging studies
In a recent study, magnetic resonance imaging (MRI) was 
performed in 38 paediatric survivors of CM. Abnormali-
ties found were focal cortical defects (16 %), sub-cortical 
T2 signal changes (18  %), atrophy (47  %), and periven-
tricular T2 signal changes (53  %). Acute papilloedema 
occurred in patients with sub-cortical T2 signal changes. 
Periventricular T2 signal changes were found in patients 
with peripheral retinal whitening [8].
A large, detailed MRI study on 152 children with CM 
was conducted in Malawi and compared findings in 
retinopathy-positive and -negative patients; MRI fea-
tures, which were more common in children with retin-
opathy were brain swelling, basal ganglia involvement, 
cortical abnormalities on T2, periventricular white mat-
ter changes, brainstem abnormalities on T2, thalamic 
involvement and corpus callosum changes on T2 and 
diffusion-weighted images, as well as cerebellar changes. 
In children with retinopathy-positive CM, it is important 
to note that some had unilateral hemispheric predomi-
nance of oedema, predominance in the globus pallidus 
and cortical involvement was noted to be “occasion-
ally markedly asymmetrical hemispheric” [9]. In a case 
of CM reported by another group, single photon emis-
sion computed tomography was performed. Focal right 
hemispheric hypoperfusion was found, which correlated 
to the patient’s right hemispheric localizing signs. Tran-
scranial dopper sonography however was normal in this 
patient. Neurological symptoms and abnormalities on 
imaging subsequently completely resolved [10]. Features 
of brain swelling were found to be more common in chil-
dren with CM compared to adults and more common in 
children, who died of CM [2]. Brain swelling may explain 
that brainstem signs and papilloedema are more com-
mon in children [4, 11].
In vivo studies of angiopathy in cerebral malaria
Retinal changes on fundoscopy and fundus fluorescein 
angiography
Recent in vivo studies on retinas in 34 Malawian children 
with CM by fluorescein angiography showed zones of 
capillary non-perfusion in 76 % of patients, involving the 
macula in 56  % and the retinal periphery in 65  %, indi-
cating the presence of obstructed retinal capillaries and 
postcapillary venules. The blood vessels affected were 
matched by retinal whitening in fundal photography. In 
26 % of patients, angiography showed large occluded ves-
sels with resulting ischemic areas in the supplied periph-
eral retina downstream. There were vessels with abrupt 
pruning of larger arterioles with normal perfusion right 
up to the point of non-perfusion. Normal angiograms in 
six patients, including two with neurological sequelae, 
indicated a lack of long-standing vaso-occlusion [12].
An observational study was performed in 42 adults 
with falciparum malaria, of which 27 patients were suf-
fering from complicated malaria. The study used bedside, 
portable, high-resolution, digital retinal photography and 
compared patients with complicated and uncomplicated 
falciparum malaria.
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Malarial retinopathy was present in 63 % of adults with 
severe malaria, in 70 % with CM and in 43 % with non-
cerebral severe malaria. The severity of retinal findings 
correlated with disease severity. Admission blood lactate 
levels correlated significantly with the severity of retinal 
and macular whitening in patients with severe malaria. 
Haematocrit on admission correlated negatively with the 
quantity of white-centred haemorrhages. The severity of 
retinal haemorrhages correlated with anaemia. Differ-
ences between retinopathy in adults and children evident 
from this study were that blood vessel discolouration 
detected in about 30  % of children with CM was not 
found in any of the adults. The vessel discolouration was 
compatible with depletion of stationary RBCs infected 
with mature parasites of haemoglobin.
Retinal whitening and discolouration of retinal blood 
vessels, but not retinal haemorrhages, were associated 
with occluded blood vessels on fluorescein angiography 
[13].
Changes of vascular tone
Peripheral arterial tonometry measures the change in 
digital pulse wave amplitude in reaction to hyperaemia 
resulting in a reactive hyperaemia peripheral arterial 
tonometry (RH-PAT) index, which provides a measure-
ment of reactive vasodilation. The arterial pulsatile vol-
ume is measured in the index finger at rest and compared 
with that obtained after an increase induced by 5  min 
of forearm ischemia (sphygmomanometer inflated to 
200 mmHg) and with values obtained in the contralateral 
index finger without reactive hyperaemia. It is known 
that the RH-PAT index is partially (≤50  %) reflecting 
endothelial nitric oxide (NO) production.
Patients with severe malaria had a significantly reduced 
RH-PAT index in the peripheral circulation compared 
to uninfected controls or patients with uncomplicated 
malaria [14].
In another study using RH-PAT, patients with severe 
malaria had a significantly lower RH-PAT index and 
cell-free haemoglobin, and plasma arginase levels were 
inversely correlated to RH-PAT indexes. In patients who 
survived >24  h after enrolment, there were significant 
associations between increase in RH-PAT index and both 
decreasing cell-free haemoglobin and increasing l-argi-
nine concentrations [15].
Changes of blood flow on cerebral Doppler studies
Cerebral vasospasm has been defined by Lindegaard 
using blood velocity measurements by transcranial Dop-
pler ultrasounds. He found that a narrowing of vessel 
diameter on angiography is associated with increased 
velocity with a ratio of >3 in middle cerebral artery to 
extracranial internal carotid artery flow diagnostic of 
vasospasm [16].
In a pioneering study, Newton et  al. investigated cer-
ebral haemodynamics by transcranial Doppler [17]. On 
investigation of 50 children with CM, in 30 % an increase 
in cerebral blood flow velocity was observed. Six of 11 
children with neurological sequelae had sonographic 
abnormalities associated with unilateral deficits, includ-
ing two children where the contralateral middle cer-
ebral artery could not be ultrasonicated and two where 
seizures were associated with a transient increase in 
Doppler velocity. In three children, who died, ultrasono-
graphic features of increased intracranial pressure were 
documented. Subsequent studies confirmed the finding 
of an increased blood flow velocity in CM [18].
The role of nitric oxide in cerebral malaria
Over recent years the role of NO in the pathogenesis 
of CM including reduction of pRBC sequestration and 
reduction of vasospasm has been increasingly recog-
nized. NO is an endogenous vasodilator produced in 
endothelium by the endothelial NO synthase (eNOS) 
enzyme. Without the presence of RBCs NO has a half-life 
of up to several minutes. It can therefore diffuse across 
cell membranes and act as an intercellular messenger. 
NO diffuses from the endothelium to nearby smooth 
muscle. There it binds to the haem group of the guanylate 
cyclase. This causes this enzyme to convert guanosine 
triphosphate (GTP) to cyclic guanosine monophosphate 
(cGMP) and cGMP then activates cGMP-dependent pro-
tein kinases and produces vasodilatation [19].
NO can down-regulate transcription of endothelial 
adhesion molecule genes, including E-selectin, VCAM-1, 
ICAM-1 and P-selectin. NO increases the expression of 
endothelin B receptors (a receptor mediating vasodilata-
tion) and decreases expression of endothelin-1, the most 
powerful endogenous vasoconstrictor [20].
Inhibition of NO production by exposure of human 
microvascular endothelial cell to the NOS inhibitor 
L-N(G)-nitro-arginine-methyl-ester (L-NAME) increased 
P. falciparum pRBC adhesion, while addition of a NO-
donor reduced adhesion. In vitro studies showed that the 
NO donor 3-(2-hydroxy-2-nitroso-1-propylhydrazino)-
1-propanamine (PPN) treatment reduced the number of 
adherent pRBCs on resting and TNF stimulated human 
microvascular endothelial cells (HMECs) by down-
regulating basal ICAM-1 expression [21]. NO effects 
therefore have features which may be protective against 
complications of P. falciparum infection by inhibition of 
cyto-adherence. Patients with CM were found to have 
decreased plasma and cerebrospinal levels of the nitric 
oxide metabolites nitrite and nitrate [22].
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Patients with CM also had reduced levels of l-Arginine, 
the substrate for NO production by nitric oxide synthase. 
Hypoargininaemia was strongly associated with mortality 
[23].
The role of haemolysis in cerebral malaria
Replication of schizonts inside RBCs leads to haemoly-
sis and therefore to production of cell-free haemoglo-
bin which after exposure to reactive oxygen species 
is oxidized. It is established that during haemolysis, 
cell-free oxyHb in the plasma acts as a NO scavenger 
leading to production of metHb and nitrate (NO3−) in 
a rapid and irreversible reaction [24]. Cell-free plasma 
haemoglobin has the potential to eliminate the major-
ity of the NO that is generated by endothelial cells 
[25]. This is counteracted by the process of catabolism 
of haem released during haemolysis by intracellular 
haem oxygenase-1 (HO-1), generating carbon monox-
ide (CO), Fe, and biliverdine. CO has been found to be 
involved in mediating the protective effect of HO-1. 
CO hereby binds to the prosthetic haem groups of cell-
free haemoglobin leading to the formation of a stable 
carboxyhaemoglobin complex resistant to oxidizing 
influences. This reduces the nitric oxide metabolizing 
capacity of free haemoglobin. The events resulting from 
haemolysis-associated nitric oxide depletion are sum-
marized in Fig.  1. More recently it was demonstrated 
that RBC microparticles generated during haemolysis 
can scavenge NO with a capacity comparable to cell-
free haemoglobin [26].
RBC arginase appears in the plasma during haemolysis 
and is in competition with NOS for the same substrate, 
l-arginine [27].
Direct evidence for a role of haemolysis in determin-
ing vascular tone in severe malaria in humans comes 
from an observational study in Indonesian adults, which 
demonstrated that reactive RH-PAT index was correlated 
with haptoglobin concentrations. Infusion of l-arginine, 
which is the substrate for the NO synthase producing 
nitric oxide, significantly increased the RH-PAT index 
[14].
Support for a role of depletion of nitric oxide by the 
haemolytic process in the pathogenesis of CM would be 
an association of elevated free haemoglobin with CM. 
This has recently been confirmed by comparison of free 
haemoglobin in children with moderately severe malaria, 
severe malaria and CM in Tanzania, where only children 
with CM had a significant elevation of plasma cell free 
haemoglobin compared to healthy controls [28].
The role of endothelins
To gather evidence for a role of vasospasm in CM 
it is essential to examine data on the association of 
vasoconstrictors with features of CM. Endothelin-1 is 
one of the most potent vasoconstrictors. Two studies 
analysing ET-1 during malaria infection in humans have 
been reported to date [29, 30]. They showed that ET-1 
was increased in patients with complicated falciparum 
malaria compared to controls. There was no correlation 
between serum levels of ET-1 and severity of disease. 
Studies conducted in vitro demonstrated that lipid com-
ponents of the parasite present in the membrane of P. 
falciparum-infected RBCs and malaria pigment (haemo-
zoin) can both bind ET-1 [31]. The authors speculated 
that non-specific binding could reduce ET-1 activity by 
decreasing its presence in the local microenvironment 
where sequestration of pRBCs occurs.
Post‑mortem examination of patients who died of cerebral 
malaria
In landmark quantitative analyses of brain sections in 
post-mortem studies of patients in Thailand and Viet-
nam, it was demonstrated that adults with CM had more 
pRBCs sequestered in the brain than patients who died 
of other complications of malaria. In addition, pRBC 
sequestration in the brain of CM patients was also more 
pronounced compared to other organs [32, 33]. Adults 
and children succumbing to CM showed significantly 
increased expression of intercellular adhesion mole-
cule-1 (ICAM-1) in the brain, which mediates adhesion 
of pRBC to the endothelium of cerebral capillaries and 
venules [34]. Inflammation involving release of tumour 
necrosis factor has been involved in up-regulation of 
ICAM-1 expression in endothelial cells and the process 
of induction of this inflammation has been reviewed else-
where [35, 36]. In an autopsy series on children who died 
of CM, 34 % were found to have no discernible cerebral 
histological changes, only minimal malarial pigment and 
very few parasites within cerebral vessels [37]. There was 
no or little detectable inducible nitric oxide synthase 
found in cerebral endothelial cells of those patients [38].
Retinal histopathology
The most extensive retinal histopathological examination 
in CM reported so far included findings of the eyes of 64 
children, including 13 cases with a clinical diagnosis of 
CM but an alternative cause of death. All patients with 
systemic pathological features of CM had prominent 
sequestration of early or late stage parasites in the reti-
nal vasculature. Haemorrhages were significantly more 
common in CM patients compared to patients with non-
malarial disease. There were significantly more thrombi 
seen in the retinal vessels of patients with CM than in the 
non-CM group. Thrombi were found to often only par-
tially occlude blood vessels and seen without surround-
ing haemorrhage [39].
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In a more recent study on the same population in 
Malawi [40] in 13 children with histologically proven 
CM, all had malarial retinopathy and showed pRBC 
sequestration in a mean of 69 % of retinal capillaries and a 
mean of 81 % of retinal venules. The percentage of pRBC 
sequestration correlated significantly with the grade 
of malaria retinopathy severity detected before death. 
There was a positive correlation of percentage of capillar-
ies with pRBC in the retina and brain. It is important to 
note that the presence of extra-erythrocytic haemozoin 
was higher in patients with moderate to severe malarial 
retinopathy compared to patients with mild malarial 
retinopathy. The authors noted vascular congestion in 
retinal venules which showed a high density of pRBCs, 
confirming a previous histopathological study conducted 
in Vietnam which demonstrated that congestion of heav-
ily parasitized cerebral micro-vessels was associated with 
a reduction of Glasgow coma scale (GCS) during coma 
and shortening of time of coma before death [41].
Treatment of cerebral malaria
Nitric oxide donors
There has been, so far, only been one published trial in 
humans addressing the bioavailability of the vasodilator 
nitric oxide. Intravenous infusion of l-Arginine (l-Arg) 
was associated with an increase in the RH-PAT index 
and led to an increase in exhaled NO levels in patients 
with moderately severe malaria [14] and was shown to 
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Fig. 1 Model for the interaction between sequestration of parasitized red blood cells (pRBC), haemolysis, nitric oxide depletion, and vasospasm. 
Red blood cells containing schizonts adhere to endothelial cells bound by intercellular adhesion molecule-1 (ICAM-1) symbolized by a vertical 
rectangle and rupture releasing free haemoglobin (oxyHb), the haem moiety of which binds nitric oxide (NO) generated by endothelial nitrix oxide 
synthase (eNOS) diverting it from diffusion to vascular smooth muscle cells and converting it to methaemoglobin (MetHb). The vascular smooth 
muscles depicted, can be distant from the site of sequestration anywhere on the arterial side of the circulation. The depletion of NO causes vaso-
constriction and increased expression of ICAM-1. Without oxy haemoglobin nitric oxide activates the vascular smooth muscle guanylate cyclase 
which generates cGMP which via activation of a protein kinase leads to muscle relaxation. Haemoxygenase (HO-1) metabolizes haem into carbon 
monoxide (CO), iron and biliverdine. CO binds haemoglobin and prevents binding of nitric oxide and hence nitric oxide metabolism
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be safe [42, 43]. In a subsequent, randomized study of 
intravenous l-Arg infusion in Indonesian adults with 
severe malaria, no effect on clearance of lactate or RH-
PAT index was detected [44]. Currently, randomized con-
trolled trials are awaiting publication [45], or are planned 
[46] exploring the effect of inhaled nitric oxide as adju-
vant treatment of CM.
Discussion
The evidence for vasospasm in cerebral malaria
This review shows that previous studies have not dem-
onstrated direct evidence of vasospasm in human CM. 
Reason for this may be that studies conducted so far 
have not used internationally recognized criteria, such as 
the Lindegaard criteria of flow ratio of >3 in middle cer-
ebral artery to extracranial internal carotid artery flow, 
or cut-offs for definition of significantly increased flow 
on Doppler ultrasound [16], to define vasospasm in CM. 
Future studies need to assess patients with this method 
for evidence of vasospasm. This method previously found 
evidence for vasospasm in bacterial meningitis where 
low GCS (<7) on admission, seizures and focal cerebral 
ischaemic deficits, were more common in patients with 
cerebral blood flow velocity >210 cm/s, compatible with 
vasospasm [47].
Data presented above provide the following lines of 
indirect evidence of cerebral vasospasm in CM:
a. The rapid reversibility of coma and neurological defi-
cits in the majority of patients with CM is consistent 
with a role of transient vasospasm and against a vas-
cular obstruction by thrombi or sequestered pRBCs;
b. The unilateral asymmetrical hemispheric changes 
on cerebral MRI and transient hemispheric changes 
on single-photon emission computed tomography. 
described in some patients are compatible with a 
transient vasospasm in a large supplying artery and 
cannot be explained by thrombi or sequestration. 
Obstruction of a large artery by thrombus or seques-
tered pRBCs has not been found on post-mortem 
studies of patients who died of CM;
c. Transient increase in Doppler flow during seizures in 
CM cannot be explained by sequestration or thrombi 
but by vasospasm. The lack of detection of middle 
cerebral artery by Doppler in patients associated with 
transient neurological deficits is also most likely due 
to transient vasospasm;
d. Normal angiograms in six patients, including two 
with neurological sequelae, indicated a lack of long-
standing vaso-occlusion more compatible with 
vasospasm than other forms of vasocclusion;
e. In a sub-group of patients, features of fatal CM were 
found without sequestration of pRBCs or thrombi 
in cerebral blood vessels on autopsy. The absence 
of inducible NO synthase (iNOS) expression in 
endothelial cells in these patients was against this 
absence of pRBCs being due to recent simultaneous 
bursting of sequestered pRBCs, which would have 
induced iNOS expression;
f. RH-PAT shows changes during malaria compatible 
with changes of nitric oxide bioavailability, which 
could predispose to and cause vasospasm.
To assess the specific contribution of vasospasm to the 
pathophysiology of CM, a comparison with a condition 
characterized by pure and isolated cerebral vasospasm 
without an underlying inflammation or haemorrhage is 
helpful. Such a condition is the so-called reversible cer-
ebral vasoconstriction syndrome (see Table 1). The syn-
drome with a review of all its features and management 
has been characterized previously [48].The features 
found in reversible cerebral vasoconstriction syndrome 
provide evidence that vasospasm causes reversible brain 
swelling and intracranial haemorrhages, as found in 
CM.
Conditions associated with ocular vasospastic syn-
drome have been associated with retinal arterial vaso-
occlusion and ischemia [49]. There is a clear causal 
link between vasospastic conditions and secondary 
cerebral haemorrhages as well as evidence for vasos-
pasm being secondary to extravasated blood. In chil-
dren with CM, haemoglobin depleted retinal blood 
vessels (secondary to haemolysis) were associated with 
non-perfusion on angiography and retinal whiten-
ing [13] compatible with a role of haemolysis in vaso-
occlusion by vasospasm.
Table 1 Features shared between cerebral malaria and cerebral vasoconstriction syndrome [2, 48]
Clinical features
 Seizures, headaches, persistent neurological deficits, including aphasia, hemiplegia, hemianopia, or cortical blindness
Radiological features
 MRI findings of sub-arachnoid and intracerebral haemorrhages, cerebral infarction, and reversible brain oedema, hyperintensities on T2 imaging 
involving the cortex and sub-cortical and deep white matter
Doppler ultrasonographic findings
 Maximum mean flow velocities in the middle cerebral arteries might be normal during the first few days after onset of symptoms
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The aetiology of brain swelling in cerebral malaria
Against a disruption of the blood brain barrier as cause 
of brain swelling in CM, is the fact that radioactively 
labelled albumin given intravenously was not found in 
cerebrospinal fluid during coma and no increase was 
found in the albumin index (ratio of concentrations 
of albumin in cerebrospinal fluid to those in blood) 
[50, 51]. Previous investigators proposed a cytotoxic 
aetiology of brain swelling from ischaemia [4]. Vasos-
pasm could be involved in such ischemia. Hypoxia in 
vasospasm-induced ischemia can lead to break down 
of the cytoskeleton which can then lead to a dysregula-
tion of membranous ion transport, which maintains the 
osmotic gradient across cell membranes and cell layers, 
and which can prevent cellular and interstitial oedema 
[52]. The rapid resolution of such oedema in survivors of 
CM is against a complete obstruction of blood vessels by 
sequestrated pRBCs or thrombi and is more compatible 
with a dominance of rapidly reversible vasospasm in its 
pathogenesis.
Another proposed explanation of brain swelling in CM 
is pooling of blood in congested cerebral veins from para-
site sequestration. Against this hypothesis is the finding 
of unilateral brain abnormalities on scanning found in 
some patients with CM, which is unlikely to occur with 
the disseminated nature of parasite sequestration affect-
ing both cerebral hemispheres.
Cerebral vasospasm is likely to be more reversible than 
sequestration. Resolution of vasospasm may be an essen-
tial requirement for reversal of sequestration by increas-
ing shearing forces by increased flow through widening 
blood vessels. Vascular resistance is crucially dependent 
on diameter. The rapid reversibility of vasospasm makes 
it the ideal target for rapid treatment of this potentially 
fatal complication of falciparum malaria.
The potential of treatments of cerebral vasospasm 
occurring in the context of sub‑arachnoid haemorrhages
To find therapeutic options for any vasospasm contribut-
ing to the pathogenesis of CM it is essential to be aware 
of all treatment that has been shown to reduce cerebral 
vasospasm rapidly in humans and has been demon-
strated to be safe in randomized controlled trials. Such 
trials have been conducted in patients with cerebral 
vasospasm associated with sub-arachnoid haemorrhages. 
A similar mechanism to sub-arachnoid haemorrhage-
associated vasospasm caused by haemolysis of extrava-
sated RBCs in the sub-arachnoid space may mediate 
vasospasm through depletion of nitric oxide and induc-
tion of endothelin-1 release in CM because of schizont 
rupture-related haemolysis as well as the breakdown 
of extravasated blood from the frequently encountered 
intracerebral microhaemorrhages associated with more 
severe disease. Treatments that were found to rapidly 
reverse cerebral vasospasm in sub-arachnoid haemor-
rhage and have been summarized previously [53] include 
calcium channel blockers, such as nimodipine or nicardi-
pine, which reduced the risk of poor outcome (depend-
ency, vegetative state or death) and secondary ischemia 
[54, 55], endothelin receptor antagonists, which reduced 
the incidence of delayed ischemic neurological deficit 
(DIND) and angiographic vasospasm [56, 57], and intra-
thecal tissue plasminogen activator, which was associated 
with significant reductions in poor outcomes, DINDs and 
angiographic vasospasm [58].
The relevance of erythropoietin in CM was demon-
strated by the fact that high levels of erythropoietin 
(EPO) were measured in African children with severe 
malarial anaemia and were associated with a 80 % reduc-
tion in the risk of neurological sequelae during CM [59]. 
EPO is found in the cerebrospinal fluid only after very 
high intravenous doses, which can have systemic, includ-
ing haematopoietic, adverse effects.
It has recently been described that the non-haemat-
opoietic and haematopoietic functions of EPO are trans-
mitted through different receptors. To reduce side effects 
of EPO, non-haematopoietic EPO derivatives have been 
generated, such as asialoEpo and carbamylated Epo 
(CEPO), that maintain their tissue-protective activities 
but do not increase the concentration of RBCs [60]. EPO 
has been used to reduce vasospasm in sub-arachnoid 
haemorrhage in a randomized controlled trial, which 
was associated with reduced DIND with new cerebral 
infarcts, a reduction of impaired auto-regulation and bet-
ter outcome at discharge [61]. There is a need for rand-
omized controlled trials using non-haematopoietic EPO 
derivatives in treatment of CM.
Reducing adverse effects of haemolysis
Future research needs to find supportive evidence for the 
role of haemolysis in CM. This can be gained indirectly 
by investigating the role of the HO-1 in CM: ferritin, 
bilirubin and iron could be measured in the cerebrospi-
nal fluid of patients with CM compared to controls with 
uncomplicated and complicated falciparum malaria, as 
they are end-products of haem metabolism by HO-1 [62].
Prevention of the effect of free haemoglobin in reduc-
ing nitric oxide bioavailability has been achieved by use 
of haptoglobin [63]. Capturing the nitric oxide scaveng-
ing haem group remaining unbound in malaria-induced 
haemolysis has been achieved by haemopexin (Hx) in 
other diseases associated with haemolysis [64].
Inhaled nitric oxide
Inhaled nitric oxide (iNO) could be particularly use-
ful as supportive treatment of CM: unlike nitric oxide 
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donors, such as nitroglycerine and sildenafil, iNO has 
not been associated with anaemia or systemic vasodila-
tation causing hypotension. Unlike NO donors, for iNO 
there is no requirement for a functional endothelial cell 
NO synthase (eNOS). eNOS may be dysfunctional in 
some patients. NO gas manufacture is affordable, and 
can be administered by mask without significant infra-
structure requirements [20] and Hawkes et  al. are cur-
rently exploring its effectiveness in reducing morbidity 
and mortality in a trial in patients with CM. In addition 
to developing application of iNO, once effective doses of 
the phosphodiesterase inhibitor-5 sildenafil, l-arginine, 
nitrite or nitroglycerin for reducing cerebral vasospasm 
are established, side effects could be minimized by using 
combinations of these agents, potentially enabling dose 
reductions of the individual agent.
Conclusions
CM remains a significant clinical problem associated 
with delayed recognition and treatment of falciparum 
malaria in endemic areas. CM is associated with signifi-
cant mortality occurring rapidly after admission to hos-
pital. Survival of CM can be associated with permanent 
neurological and neurocognitive deficits. The key events 
in the pathophysiology of CM may be vaso-occlusion 
by sequestration of pRBCs and vasospasm. Haemoly-
sis resulting from rupture of adherent schizonts may 
cause depletion of nitric oxide by binding of nitric oxide 
to free haem released by this haemolytic process. Nitric 
oxide depletion causes vasospasm and increases pRBC 
adhesion by up-regulation of intercellular adhesion mol-
ecule-1 expression. Strategies relieving cerebral vasos-
pasm are most likely to rapidly reverse coma and reduce 
the risk of ischemic neurological deficit in CM.
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